new_0222_0329|RVMD|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0329|RVMD|1|Revolution Medicines Inc Total Current Assets (Quarterly) (USD)|Revolution Medicines Inc Cash and Short Term Investments (Quarterly) (USD)|Revolution Medicines Inc Inventories (Quarterly) (USD)|Revolution Medicines Inc Net PP&E (Quarterly) (USD)|Revolution Medicines Inc Goodwill and Intangibles (Quarterly) (USD)|Revolution Medicines Inc Total Liabilities (Quarterly) (USD)|Revolution Medicines Inc Total Current Liabilities (Quarterly) (USD)|Revolution Medicines Inc Total Long Term Liabilities (Quarterly) (USD)|Revolution Medicines Inc Total Deposits (Quarterly) (USD)|Revolution Medicines Inc Book Value (Quarterly) (USD)|Revolution Medicines Inc Retained Earnings (Quarterly) (USD)|Revolution Medicines Inc Treasury Stock (Quarterly) (USD)|Revolution Medicines Inc EV to Revenues|Revolution Medicines Inc EV to Earnings|Revolution Medicines Inc EV to Free Cash Flow|Revolution Medicines Inc EV to Assets (Quarterly)|Revolution Medicines Inc PS Ratio|Revolution Medicines Inc PE Ratio|Revolution Medicines Inc Price to Book Value|Revolution Medicines Inc PEG Ratio|Revolution Medicines Inc Debt to Equity Ratio|Revolution Medicines Inc Dividend Yield|Revolution Medicines Inc Shareholder Yield (TTM)|Revolution Medicines Inc Percent of Shares Outstanding Short|Revolution Medicines Inc Total Receivables (Quarterly) (USD)|Revolution Medicines Inc Total Payables (Quarterly) (USD)|Revolution Medicines Inc Total Capital Stock (Quarterly) (USD)|Revolution Medicines Inc Return on Invested Capital|Revolution Medicines Inc Quality Ratio Score|Revolution Medicines Inc Momentum Score|Revolution Medicines Inc Beta (1Y)|Revolution Medicines Inc Sustainable Growth Rate (TTM)|Revolution Medicines Inc Institutional Investor Ownership Percentage|Revolution Medicines Inc Average Diluted Shares Outstanding (Quarterly)|Revolution Medicines Inc Total Employees (Annual)|Revolution Medicines Inc EPS Diluted (Quarterly) (USD)|Revolution Medicines Inc Shares Outstanding|Revolution Medicines Inc Repurchase of Capital Stock (Quarterly) (USD)|Revolution Medicines Inc Ordinary Shares Number (Quarterly)|Revolution Medicines Inc Payout Ratio|Revolution Medicines Inc Quick Ratio (Quarterly)|Revolution Medicines Inc Normalized Diluted EPS (Quarterly) (USD)|Revolution Medicines Inc Stock Buybacks (Quarterly) (USD)|Revolution Medicines Inc Effective Tax Rate (TTM)|Revolution Medicines Inc Return on Equity|Revolution Medicines Inc Net Income (TTM) (USD)|Revolution Medicines Inc Revenue (TTM) (USD)|Revolution Medicines Inc Dividend Per Share (Quarterly) (USD)|Revolution Medicines Inc Revenue (Quarterly) (USD)|Revolution Medicines Inc Gross Profit (Quarterly) (USD)|Revolution Medicines Inc SG&A Expense (Quarterly) (USD)|Revolution Medicines Inc Pre-Tax Income (Quarterly) (USD)|Revolution Medicines Inc Net Income (Quarterly) (USD)|Revolution Medicines Inc Net Interest Income (Quarterly) (USD)|Revolution Medicines Inc Price (USD)|Revolution Medicines Inc Total Return Price (USD)|Revolution Medicines Inc Enterprise Value (USD)|Revolution Medicines Inc 30-Day Average Daily Volume|Revolution Medicines Inc 1 Year Price Returns (Daily)||
new_0222_0329|RVMD|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0329|RVMD|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|daily|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0329|RVMD|5|111.555555556|111.555555556|0|111.555555556|111.555555556|111.555555556|111.555555556|111.555555556|0|111.555555556|111.555555556|0|1.44642857143|91.3333333333|1.44642857143|91.3333333333|1.44642857143|0|1.44491525424|1.44637681159|91.2727272727|1.44642857143|91.3333333333|15.2553191489|111.555555556|111.555555556|111.555555556|91.2857142857|0|34|30.6363636364|91.3333333333|0|91.2727272727|91.375|91.2727272727|30.4761904762|92|111.555555556|91.375|91.2727272727|91.2727272727|91.4|91.2857142857|91.3333333333|91.375|91.375|0|91.2727272727|0|91.2727272727|91.2727272727|91.2727272727|91.2727272727|1.44642857143|1.44642857143|1.44642857143|1.44631578947|1.43426294821||
new_0222_0329|RVMD|6|9|9|0|9|9|9|9|9|0|9|9|0|504|6|504|6|504|0|472|345|11|504|6|47|9|9|9|7|0|9|11|6|0|11|8|11|21|1|9|8|11|11|10|7|6|8|8|0|11|0|11|11|11|11|504|504|504|475|251||
new_0222_0329|RVMD|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0329|RVMD|201812|85.431|69.586||6.872|77.69|73.927|30.552|43.375||-108.422|-109.722||||||||||0||||7.303|5.236|205.081|||||||36.4731||-0.38|||52.9023||2.5167|-0.3109|||||||10.347||3.835|-11.339|-11.339|0.33|||||||
new_0222_0329|RVMD|201903||||||||||||||||||||||||||||||||||36.4731||-0.3511||||||-0.2778|0||||||13.166||2.416|-10.131|-10.131|0.305|||||||
new_0222_0329|RVMD|201906||||||||||||||||||||||||||||||||||36.4731||-0.3614||||||-0.2774|0||||||12.281||2.725|-10.119|-10.119|0.442|||||||
new_0222_0329|RVMD|201909|149.117|136.288||6.78|76.888|69.077|38.64|30.437||165.668|-142.79||||||||||0||||8.95|6.013|0.004|||||||36.4731|90|-0.4679|||52.9023|0|3.7587|-0.3514||||-44.407|48.3||12.506||3.103|-12.818|-12.818|0.741|||||||
new_0222_0329|RVMD|201912|133.981|122.758||7.147|76.621|67.994|43.052|24.942||-152.574|-157.386||40.5138||-38.8345||25.3582||||0|0||1.1514|8.737|11.4|305.109|-34.4674||||||52.9023|95|-0.3563|58.996||52.9023|0|3.0543|-0.2759|0|8.4036||-47.664|50.041||12.088||4.162|-18.969|-14.596|0.595|31.27|31.27|2027.3529||||
new_0222_0329|RVMD|202003|362.086|347.948||15.243|76.354|69.025|41.514|27.511||385.316|-176.905||19.5126|-16.5607|-13.919|2.0795|17.5505||3.3551||0|0|-19.6259|2.6325|8.45|7.877|0.006|-24.3286||||-78.6957||29.2977|100|-0.74|59.0036||59.0036|0|8.585|-0.74|-253.717|8.1288|-78.6957|-57.052|48.421||11.546||5.171|-20.194|-19.519|0.888|21.91|21.91|944.8209|488372.0333||31.27|30.72
new_0222_0329|RVMD|202006|340.381|325.445||35.994|76.087|93.459|43.737|49.722||360.498|-204.12||33.3085|-20.7381|-20.1764|3.3873|30.3332||5.1682||0|0|-13.5414|2.6999|7.331|10.173|0.006|-27.8747||||-56.9943||58.7525|106|-0.46|59.0159|-0.005|59.0159|0|7.6086|-0.46|1.422|6.4426|-56.9943|-74.148|46.165||10.025||5.091|-27.273|-27.215|0.711|31.57|31.57|1537.687|179406.5||24.12|28.34
new_0222_0329|RVMD|202009|482.898|466.14||35.229|75.82|90|42.384|47.616||505.07|-231.341||39.766|-20.8012|-20.7065|3.0954|38.6627||4.5699|-0.6607|0|0|-18.2011|5.0741|9.299|6.656|0.007|-28.2174||||-35.0287||64.8929|117|-0.42|66.3248|0.005|66.3248|0|11.2174|-0.42|-167.806|5.4518|-35.0287|-88.551|46.32||12.661||5.341|-27.221|-27.221|0.33|34.8|34.8|1841.963|548891.9667||30.19|43.63
new_0222_0329|RVMD|202012|454.122|440.741||36.337|75.553|92.725|47.176|45.549||474.676|-265.545||51.0886|-20.3029|-21.3204|3.8702|50.5079||5.5547|-0.4712|0|0|-15.9317|5.0751|6.393|12.609|0.007|-28.7949|||2.2382|-34.3802||66.4035|125|-0.52|66.5997||66.5997|0|9.478|-0.52|0.034|0.3418|-34.3802|-108.159|42.983||8.751||5.825|-33.842|-34.204|0.238|39.59|39.59|2195.9411|459328.8|37.7148|42.14|45.68
new_0222_0329|RVMD|202103|697.405|681.593||37.574|75.286|89.071|43.759|45.312||722.58|-302.721||64.6557|-21.3614|-23.3297|3.3113|71.8721||4.6627|-103.0026|0|0|-13.2987|8.4629|7.564|9.65|0.008|-25.6962||7|2.0874|-25.6962||70.4201|131|-0.53|73.4351||73.4351|0|15.7489|-0.53|-281.709|-0.2422|-25.6962|-125.816|41.568||10.131||6.67|-37.176|-37.176|0.221|45.88|45.88|2687.6094|506597.9667|109.4021|33.19|29.91
new_0222_0329|RVMD|202106|661.011|646.322||36.669|75.018|89.04|45.801|43.239||685.006|-347.02||41.9724|-11.8195|-12.9795|2.1821|54.2493||3.4092|-6.7676|0|0|-19.2228|13.0549|6.527|10.435|0.008|-26.0023||2|1.0433|-26.0023||73.3997|150|-0.6|73.577||73.577|0|14.254|-0.6|0.564|-0.254|-26.0023|-142.9|40.241||8.698||7.297|-44.299|-44.299|0.236|31.74|31.74|1689.012|830899.0333|0.5385|28.64|29.09
new_0222_0329|RVMD|202109|623.536|608.655||35.341|74.751|96.772|51.891|44.881||638.204|-399.96||49.4261|-8.4071|-10.1646|1.9288|68.0434||3.1749|-0.5826|0|0|-13.8735|13.9847|7.412|10.491|0.008|-27.866||3|2.1915|-27.866||73.5357|162|-0.72|73.6549||73.6549|0|11.8723|-0.72|0|-0.2151|-27.866|-168.619|28.681||1.101||7.791|-52.94|-52.94|0.223|27.51|27.51|1417.5913|471970.4667|-20.9483|29.43|27.66
new_0222_0329|RVMD|202112|||||||||||||43.4451||-8.9346||62.2556||2.9061|-0.5331||0||11.166||||||2|-0.1788||||||||||||||||||||||||25.17|25.17|1246.0493|449107.6|-36.4233|21.52|21.47